Gerald Appel, MD

Gerald Appel, MD, is a professor of clinical medicine, director of clinical nephrology, and director of the Glomerular Disease Center at Columbia University.

Articles by Gerald Appel, MD

Rare Disease Day 2026: Kidney Diseases Enter Optimistic Therapeutic Era

ByGerald Appel, MD,Luis Russo, MD, MS,Swati Arora, MD,Sayna Norouzi, MD

February 28th 2026

On Rare Disease Day 2026, clinicians share their perspective on the evolving landscape for IgAN and C3G.

Expert Perspectives: Iptacopan FDA Approval for C3 Glomerulopathy

ByGerald Appel, MD,Andrew Bomback, MD, MPH,Jared Hassler, MD

March 21st 2025

A trio of nephrology experts discuss the significance of iptacopan’s FDA approval as the first treatment for C3G.

Latest Updated Articles

Rare Disease Day 2026: Kidney Diseases Enter Optimistic Therapeutic Era
February 28th 2026

Gerald Appel, MD

Articles by Gerald Appel, MD

Rare Disease Day 2026: Kidney Diseases Enter Optimistic Therapeutic Era

Expert Perspectives: Iptacopan FDA Approval for C3 Glomerulopathy

Latest Updated Articles

Trending on HCPLive

REMAIN-1: Improved GLP-1-Induced Weight Loss Retention With Revita DMR System

SYMPHONY-PE: Early Thrombectomy Improves Pulmonary Embolism Outcomes

AXIOMATIC-TKR: Milvexian Decouples Thrombosis, Hemostasis in DVT

FDA Grants Obinutuzumab Priority Review as Primary Membranous Nephropathy’s Potential First Therapy

ABCs in Dermatology: Updates in Psoriasis Management for 2026